Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy

Multiple cytokines and inflammatory markers control TB infection. We aimed to investigate the changes in multiple cytokines and inflammatory markers in active TB patients following anti-TB drug therapy. Twenty-nine patients with active TB were recruited prospectively between December 2010 and July 2017. Blood samples were collected before (T0), after 2 months (T2), and at the end of anti-TB treatment (Tend). We measured the levels of Interferon (IFN)-γ, interleukin (IL)-2, IL-12, IL-10, IL-13 and tumor necrosis factor (TNF)-α in supernatants collected from the QuantiFERON-TB Gold In-Tube assay (QFT-GIT), as well as the WBC, neutrophil, platelet count and neutrophil to lymphocyte ratio (NLR) in whole blood. Compared with baseline levels, WBC, neutrophil, and platelet counts were significantly lower following treatment. In addition, the NLR after treatment significantly decreased compared with baseline, whereas the IL-2/IFN-γ ratio increased after treatment. In conclusion, the levels of IL-2/IFN-γ ratios in the supernatant and the NLR might be useful biomarkers to evaluate the effectiveness of drug therapy in active TB patients.

[1]  Sang-Nae Cho,et al.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. , 2010, Chest.

[2]  Z. Toossi,et al.  Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study , 2008, BMC infectious diseases.

[3]  S. Iliaz,et al.  Value of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis , 2014, Annals of thoracic medicine.

[4]  T. Perneger,et al.  Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis? , 2009, Respiratory medicine.

[5]  M. Amicosante,et al.  Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study , 2008, PloS one.

[6]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[7]  K. Higuchi,et al.  Interferon‐γ responses after isoniazid chemotherapy for latent tuberculosis , 2008, Respirology.

[8]  T. van der Poll,et al.  The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia , 2012, PloS one.

[9]  Sang-Nae Cho,et al.  Association of Antigen-Stimulated Release of Tumor Necrosis Factor-Alpha in Whole Blood with Response to Chemotherapy in Patients with Pulmonary Multidrug-Resistant Tuberculosis , 2010, Respiration.

[10]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[11]  M. Kurimoto,et al.  Human host defense and cytokines in mycobacterial infectious diseases: interleukin-18 cannot compensate for genetic defects in the interleukin-12 system. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Son,et al.  Role of the Neutrophil-Lymphocyte Count Ratio in the Differential Diagnosis between Pulmonary Tuberculosis and Bacterial Community-Acquired Pneumonia , 2013, Annals of laboratory medicine.

[13]  J. Kirman,et al.  Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. , 2007, Tuberculosis.

[14]  J. Park,et al.  Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis. , 2013, Cytometry. Part B, Clinical cytometry.

[15]  A. Cooper,et al.  Cell-mediated immune responses in tuberculosis. , 2009, Annual review of immunology.

[16]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[17]  P. Klenerman,et al.  Dynamic Relationship between IFN-γ and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load1 , 2007, The Journal of Immunology.

[18]  D. Goletti,et al.  IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. , 2013, The Journal of infection.

[19]  M. Amicosante,et al.  Selected RD1 Peptides for Active Tuberculosis Diagnosis: Comparison of a Gamma Interferon Whole-Blood Enzyme-Linked Immunosorbent Assay and an Enzyme-Linked Immunospot Assay , 2005, Clinical Diagnostic Laboratory Immunology.

[20]  Y. Li,et al.  Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis. , 2015, Genetics and molecular research : GMR.

[21]  Gerhard Walzl,et al.  Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response , 2016, Oncotarget.

[22]  M. Olivier,et al.  TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.

[23]  D. Mitra,et al.  Foxp3+ Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-γ Producing T Cells , 2012, PloS one.

[24]  G. Ippolito,et al.  IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy , 2011, BMC infectious diseases.

[25]  Ajit Lalvani,et al.  Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis , 2010, PloS one.

[26]  M. Amicosante,et al.  Identification of Early Secretory Antigen Target-6 Epitopes for the Immunodiagnosis of Active Tuberculosis , 2003, Molecular medicine.

[27]  Joon Chang,et al.  The Responses of Multiple Cytokines Following Incubation of Whole Blood from TB Patients, Latently Infected Individuals and Controls with the TB Antigens ESAT‐6, CFP‐10 and TB7.7 , 2012, Scandinavian journal of immunology.

[28]  A. C. Tanrıkulu,et al.  The Relationship Between Inflammatory Marker Levels and Pulmonary Tuberculosis Severity , 2014, Inflammation.

[29]  R. Záhorec.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.

[30]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[31]  P. Andersen,et al.  Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells , 2013, The Journal of Immunology.

[32]  T. Ottenhoff,et al.  Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood , 2011, PloS one.

[33]  T. Ottenhoff,et al.  Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. , 2010, International immunology.

[34]  T. Bodmer,et al.  Clinical Significance of Interleukin-2/Gamma Interferon Ratios in Mycobacterium tuberculosis-Specific T-Cell Signatures , 2011, Clinical and Vaccine Immunology.

[35]  H. Zar,et al.  Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children , 2010, BMC infectious diseases.

[36]  S. Hasnain,et al.  In Vitro Levels of Interleukin 10 (IL-10) and IL-12 in Response to a Recombinant 32-Kilodalton Antigen of Mycobacterium bovis BCG after Treatment for Tuberculosis , 2008, Clinical and Vaccine Immunology.

[37]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[38]  R. Joshi,et al.  Serial testing of health care workers for tuberculosis using interferon-gamma assay. , 2006, American journal of respiratory and critical care medicine.

[39]  C. Bolliger,et al.  Diagnostic tools in tuberculous pleurisy: a direct comparative study , 2003, European Respiratory Journal.

[40]  P. V. van Helden,et al.  Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis , 2008, Clinical and experimental immunology.

[41]  Juan Chen,et al.  Mycobacterium tuberculosis EIS gene inhibits macrophage autophagy through up-regulation of IL-10 by increasing the acetylation of histone H3. , 2016, Biochemical and biophysical research communications.

[42]  E. Günay,et al.  Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease: A Retrospective Study , 2013, Inflammation.

[43]  M. Torres,et al.  Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen ofMycobacterium tuberculosis , 1998, Infection and Immunity.

[44]  R. Joshi,et al.  Serial testing of health care workers for tuberculosis using interferon-γ assay , 2006 .

[45]  Ifedayo M. O. Adetifa,et al.  Expanded Polyfunctional T Cell Response to Mycobacterial Antigens in TB Disease and Contraction Post-Treatment , 2010, PloS one.

[46]  R. Adegbola,et al.  Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases , 2006, BMC infectious diseases.